TG4010 Immunotherapy Combined with First-line Therapy in Advanced Non- Small Cell Lung Cancer (NSCLC). Phase 2b Results of the TIME Study

Elisabeth Quoix, et al.
Journal for Immunotherapy of Cancer, 2014, 2 (suppl. 3), O12 – Download the article
Publication

Par alcyon|2019-07-03T10:03:16+02:00novembre 12th, 2014|Publication, TG4010|Commentaires fermés